loadpatents
Patent applications and USPTO patent grants for Sajadi; Mohammad.The latest application filed is for "anti-hiv antibodies".
Patent | Date |
---|---|
Methods of making active antibodies from biological fluids Grant 11,067,583 - Sajadi , et al. July 20, 2 | 2021-07-20 |
Anti-hiv Antibodies App 20210040185 - CAVET; Guy L. ;   et al. | 2021-02-11 |
Anti-hiv Antibodies App 20210040184 - CAVET; Guy L. ;   et al. | 2021-02-11 |
Broadly Neutralizing Antibodies Against Hiv App 20200239551 - Sajadi; Mohammad ;   et al. | 2020-07-30 |
Methods Of Making Active Antibodies From Biological Fluids App 20200182883 - Sajadi; Mohammad ;   et al. | 2020-06-11 |
Broadly Neutralizing Antibodies Against Hiv App 20200172601 - Sajadi; Mohammad ;   et al. | 2020-06-04 |
Recombinant fusion protein comprising HIV gp120 linked to an enhancing CD4 binding site mAb Grant 9,951,106 - Guan , et al. April 24, 2 | 2018-04-24 |
Hiv-1 Env-binding Antibodies, Fusion Proteins, And Methods Of Use App 20150299268 - GUAN; Yongjun ;   et al. | 2015-10-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.